Clinical Trials Browser

Has announcements × durvalumab × Genitourinary × Clear all

NCT03732677 2026-03-13

NIAGARA

Phase 3 Active not recruiting

1,063 enrolled 15 charts 1 FDA

Urinary Bladder Neoplasms